3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Classical hematology
1
Conditions
Thrombocytopenia
1
Pyruvate Kinase Deficiency of Red Cells
1
Polycystic Kidney, Autosomal Recessive
1
Neurofibromatosis-Noonan syndrome
1
Neurofibromatoses
1
Myotonic Dystrophy
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Muscular Dystrophy, Duchenne
1
Leukemia, Myeloid, Acute
1
Hydrocephalus, X-linked
1
Huntington Disease
1
Hemophilia B
1
Hemophilia A
1
Hematologic Neoplasms
1
Fragile X Syndrome
1
Cystic Fibrosis
1
Anemia, Sickle Cell
1
Anemia, Hemolytic, Congenital
1
Anemia, Hemolytic
1
Interventions
eltrombopag
14
romiplostim
7
avatrombopag
7
Platelet Transfusion
6
Cytarabine
6
Radiotherapy
4
Filgrastim
4
Etoposide
4
Carboplatin
4
oprelvekin
3
Tranexamic Acid
3
Peripheral Blood Stem Cell Transplantation
3
Daunorubicin
3
Cyclophosphamide
3
Busulfan
3
hetrombopag
2
fludarabine phosphate
2
Tretinoin
2
Thrombopoietin
2
Lenalidomide
2
Interleukin-11
2
Ifosfamide
2
Granulocyte Colony-Stimulating Factor
2
Doxorubicin
2
Cyclosporine
2
Amplified Fragment Length Polymorphism Analysis
2
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
2
sodium thiosulfate
1
siltuximab
1
sargramostim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Thrombocytopenia
×
Blood Specimen Collection
×
Classical hematology
×
Clear all
NCT06455553
2025-02-13
VISCOTHEM-1
Centre Hospitalier Annecy Genevois
Phase NA
Completed
48 enrolled